The Role of Nutraceuticals in Statin Intolerant Patients
Key result
Nutraceuticals offer alternative lipid lowering in statin intolerance, but long-term cardiovascular outcome data remain lacking.
Why the study?
Do nutraceuticals reduce LDL cholesterol and improve cardiovascular outcomes in statin-intolerant patients?
Key Points
- To establish expert recommendations on using lipid-lowering nutraceuticals to manage patients experiencing statin-associated muscle symptoms and intolerance.
- Synthesized evidence evaluating nutraceuticals (red yeast rice, bergamot, berberine, artichoke, soluble fiber, plant sterols/stanols) alone or combined with ezetimibe.
- Evaluated lipid-lowering performance, secondary pleiotropic mechanisms, and existing data gaps regarding long-term cardiovascular outcomes.
- Specific nutraceuticals demonstrate substantial low-density lipoprotein cholesterol reduction alongside pleiotropic anti-inflammatory, antioxidative, and endothelial-protective properties.
- Long-term clinical evidence confirming safety and direct cardiovascular disease risk reduction remains currently insufficient, warranting cautious application as alternative or add-on regimens.
Structured PICO
Do nutraceuticals reduce LDL cholesterol and improve cardiovascular outcomes in statin-intolerant patients?
P
Population
Statin-intolerant patients with cardiovascular disease
I
Intervention
Nutraceuticals (red yeast rice, bergamot, berberine, artichoke, soluble fiber, and plant sterols and stanols) alone or in combination with each other, or with ezetimibe
O
Outcome
Low-density lipoprotein cholesterol reductionsurrogate
Limitations
- Insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“This approach begins with assessment, screening for secondary disorders and drug interactions followed by a change to another statin, dose reduction of the statin, alternate-day statin therapy, and possibly nutraceuticals.”
“The lower rate of muscle pain with nutraceuticals than with statins depends on some aspects such as dosage, combination regimens, and purification. If RYR is used, the higher-dosed products have the same probability of side effects as statins, because the mechanism of action is the same. The use of combined nutraceuticals with different mechanisms of action reduces the risk for side effects related to higher dosages of single products. The degree of purification is also important. Highly standardized products are preferable, because they reduce the risk for contamination and side effects.”
Implication
Nutraceuticals represent a potential alternative or add-on therapy for managing LDL cholesterol in statin-intolerant patients, though long-term outcome data are lacking.
Abstract
Statins are the most common drugs administered for patients with cardiovascular disease. However, due to statin-associated muscle symptoms, adherence to statin therapy is challenging in clinical practice. Certain nutraceuticals, such as red yeast rice, bergamot, berberine, artichoke, soluble fiber, and plant sterols and stanols alone or in combination with each other, as well as with ezetimibe, might be considered as an alternative or add-on therapy to statins, although there is still insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment. These nutraceuticals could exert significant lipid-lowering activity and might present multiple non-lipid-lowering actions, including improvement of endothelial dysfunction and arterial stiffness, as well as anti-inflammatory and antioxidative properties. The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Banach et al. (2018) conducted a review in Statin intolerance in cardiovascular disease. Nutraceuticals (red yeast rice, bergamot, berberine, artichoke, soluble fiber, plant sterols and stanols) was evaluated. Nutraceuticals may serve as alternative or add-on lipid-lowering therapies for statin-intolerant patients, though long-term cardiovascular outcome data remain insufficient.